Display Settings:

Format

Send to:

Choose Destination
    Int J Radiat Oncol Biol Phys. 1996 Sep 1;36(2):345-9.

    Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity.

    Source

    Toledo Community Clinical Oncology Program, OH, USA.

    Abstract

    PURPOSE:

    Considerable pilot data and clinical experience suggested that an aloe vera gel might help to prevent radiation therapy-induced dermatitis.

    METHODS AND MATERIALS:

    Two Phase III randomized trials were conducted. The first one was double blinded, utilized a placebo gel, and involved 194 women receiving breast or chest wall irradiation. The second trial randomized 108 such patients to aloe vera gel vs. no treatment. Skin dermatitis was scored weekly during both trials both by patients and by health care providers.

    RESULTS:

    Skin dermatitis scores were virtually identical on both treatment arms during both of the trials. The only toxicity from the gel was rare contact dermatitis.

    CONCLUSIONS:

    This dose and schedule of an aloe vera gel does not protect against radiation therapy-induced dermatitis.

    PMID:
    8892458
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk